Moderna coronavirus vaccine trial at CU Anschutz shows 94.5% efficacy

More than a quarter million people in the United States and some 3,100 Coloradans have died of COVID-19 as of this date, but good news is on the horizon. Recently Moderna Therapeutics announced early analysis that found its coronavirus vaccine to be 94.5% effective. CU on the Air speaks with Dr. Thomas Campbell, professor of medicine and infectious disease and leader of the Moderna vaccine trials at the CU Anschutz Medical Campus.